Skip to main content

Table 2 Allelic and genotypic frequencies of KIR and HLA-B Bw4-I80 in patients with AS and B27 healthy controls in Spanish and Azorian populations.

From: Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations

Genotypes

Spanish AS (2 n = 142)

Spanish controls (2 n = 210)

p

OR (95%CI)

Azorean AS (2 n = 110)

Azorean controls (2 n = 114)

p

OR (95%CI)

3DS1

61 (42.9%)

47 (22.3%)

<0.0001

2.6 (1.64–4.15)

39 (35.4%)

20 (17.5%)

<0.003

2.58 (1.38–4.8)

3DL1

81 (57%)

163 (77.6%)

<0.0001

0.3 (0.24–0.6)

71 (64.5%)

94 (82.4%)

<0.003

0.38 (0.2–0.72)

Bw4I80

24 (16.9%)

40 (19%)

NS

-

18 (16.3%)

17 (14.9%)

NS

-

Genotypes

Spanish AS ( n = 71)

Spanish controls ( n = 105)

  

Azorean AS ( n = 55)

Azorean controls ( n = 57)

  

3DL1/3DL1

25 (35.2%)

65 (61.9%)

0.0008

0.33 (0.17–0.62)

20 (36.3%)

39 (68.4%)

<0.001

0.26 (0.12–0.57)

3DS1/3DS1

15 (21.1%)

7 (6.6%)

0.0009

3.75 (1.44–9.74)

4 (7.2%)

2 (3.5%)

NS

-

3DS1/3DL1

31 (43.6%)

33 (31.4%)

NS

-

31 (56.1%)

16 (28%)

0.005

3.3 (1.50–7.26)

3DS1/Bw4I80 +

22 (30.9%)

16 (15.2%)

0.02

2.49 (1.2–5.19)

15 (27.2%)

5 (8.7%)

0.01

4.4 (1.48–13.37)

3DS1/Bw4I80 -

24 (33.8%)

24 (22.8%)

NS

-

20 (36.3%)

13 (22.8%)

NS

-

3DL1/Bw4I80 +

14 (19.7%)

37 (35.2%)

0.03

0.45 (0.22–0.91)

9 (16.3%)

16 (28%)

NS

-

3DL1/Bw4I80 -

42 (59.1%)

61 (58.1%)

NS

-

36 (64.4%)

39 (68.4%)

NS

-

  1. AS, ankylosing spondylitis; CI, confidence interval; HLA, human leukocyte antigen; KIR, killer cell immunoglobulin-like receptor; NS, not significant; OR, odds ratio.